Bronchiectasis: Clinical Trials

14 trials for Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 14

Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
Tobramycin Inhalant Product, Ciprofloxacin 750 MG, Oral ciprofloxacin placebo - Bronchiectasis Adult, Pseudomonas Aeruginosa Infection
Phase 4CompletedJin-Fu Xu3712023-10-182026-04-17
Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.
Nebulized 5% Hypertonic saline - Bronchiectasis
Phase 4CompletedUniversity of Malaya462021-02-042023-12-01
Prevention of OM-85 on Bronchiectasis Exacerbation
OM-85 BV - Bronchiectasis With Acute Exacerbation
Phase 4CompletedChinese Academy of Medical Sciences1962015-03-012020-04-21
Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations
Duration, Colomycin, Meropenem - Bronchiectasis
Phase 4CompletedUniversity of Edinburgh902014-01-012020-05-04
The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
Formoterol-budesonide, Theophylline, Placebo - Bronchiectasis
Phase 4CompletedThe First Affiliated Hospital of Guangzhou Medical University502013-07-012015-03-11
The Effect of Theophylline in the Treatment of Bronchiectasis
Theophylline, Placebo(for Theophylline) - Bronchiectasis
Phase 4CompletedThe First Affiliated Hospital of Guangzhou Medical University1002012-11-012015-03-11
Efficacy of Azithromycin in Treatment of Bronchiectasis
Azithromycin, Placebo for Azithromycin - Bronchiectasis
Phase 4CompletedPenang Hospital, Malaysia782011-11-012014-07-18
Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis
ICS+LABA, routine therapy - Bronchiectasis
Phase 4CompletedShanghai Pulmonary Hospital, Shanghai, China1202011-06-012016-05-26
Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa
ATORVASTATIN - BRONCHIECTASIS
Phase 4CompletedUniversity of Edinburgh322010-11-012017-05-03
A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis
Atorvastatin - Bronchiectasis
Phase 4CompletedUniversity of Edinburgh602010-11-012013-08-28
Pulmonary Rehabilitation in Non Cystic Fibrosis Bronchiectasis
Chest physiotherapy, Chest Physiotherapy + Exercise Program - Bronchiectasis
Phase 4CompletedNHS Lothian272009-03-012011-11-08
Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic Hypersecretion
TPEP device (UNIKO), MABT (Manually assisted breathing techniques) - Chronic Hypersecretions
Phase 4CompletedVilla Pineta Hospital1002008-07-012011-08-04
Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?
Acapella Physiotherapy - Bronchiectasis
Phase 4CompletedNHS Lothian202007-10-012011-04-01
Long Term Nebulised Gentamicin in Patients With Bronchiectasis
Gentamicin, Saline - Bronchiectasis
Phase 4CompletedUniversity of Edinburgh602007-05-012010-08-10

Narrower conditions

Inflammation (2)  ·  Pseudomonas Infections (2)  ·  Bronchitis, Chronic (1)  ·  Chronic Cough (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Bronchial Diseases (14)  ·  Respiratory Tract Diseases (14)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Infections (3)  ·  Pathologic Processes (3)  ·  Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Bronchitis (1)  ·  Chronic Disease (1)  ·  Cough (1)  ·  Disease Attributes (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Respiration Disorders (1)

Interventions

Atorvastatin (2)  ·  Theophylline (2)  ·  Anti-Bacterial Agents (1)  ·  Azithromycin (1)  ·  Broncho-Vaxom (1)  ·  Ciprofloxacin (1)  ·  Fluticasone-Salmeterol Drug Combination (1)  ·  Gentamicins (1)  ·  Meropenem (1)  ·  Saline Solution, Hypertonic (1)  ·  Sodium Chloride (1)  ·  Tablets (1)  ·  Time (1)

Sponsors

University of Edinburgh (4)  ·  NHS Lothian (2)  ·  The First Affiliated Hospital of Guangzhou Medical University (2)  ·  Chinese Academy of Medical Sciences (1)  ·  Jin-Fu Xu (1)  ·  Penang Hospital, Malaysia (1)  ·  Shanghai Pulmonary Hospital, Shanghai, China (1)  ·  University of Malaya (1)  ·  Villa Pineta Hospital (1)

Countries

United Kingdom (6)  ·  China (5)  ·  Malaysia (2)  ·  Italy (1)

Top investigators

Adam T Hill, MBChB MD (4)  ·  Chen Rongchang, Professor (2)  ·  Zhong Nanshan, Professor (2)  ·  Adam T Hill, MBCHB, MRCP, MD (1)  ·  Adam T Hill, MD, FRCPE (1)  ·  Anna M Nathan (1)  ·  Enrico M. Clini, MD (1)  ·  Jin-Fu Xu (1)  ·  Jin-Fu Xu, MD, PhD (1)  ·  Jinming Gao, M.D. (1)  ·  Nicolino Ambrosino, MD (1)

Results publications

PMID 11511368, PMID 12403874, PMID 1285737, PMID 12927665, PMID 15672845, PMID 15741443, PMID 17053496, PMID 18006882, PMID 18828160, PMID 19541717, PMID 20585638, PMID 20864608, PMID 20870753, PMID 21330456, PMID 21458735, PMID 21778259, PMID 21830316, PMID 21885727, PMID 22018993, PMID 22349069, PMID 22744718, PMID 22947443, PMID 23146374, PMID 23630581, PMID 23646159, PMID 24482322, PMID 24521788, PMID 24717640, PMID 24773830, PMID 24913725, PMID 25183304, PMID 25307313, PMID 25516281, PMID 25638182, PMID 26842959, PMID 27214047, PMID 28232410, PMID 28265556, PMID 28554732, PMID 29225146, PMID 30215382, PMID 31023759, PMID 31055386, PMID 31409413, PMID 31475469, PMID 34112732, PMID 3533593, PMID 36746812